p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced

M Omura-Minamisawa1, M B Diccianni, R C Chang

  • 1Department of Pediatrics/Hematology-Oncology, University of California San Diego Medical Center, 200 West Arbor Drive, San Diego, CA 92103, USA.

Insights

Up-regulated p16 expression is more common in aggressive neuroblastoma and linked to poorer survival. This suggests elevated p16 may be a unique marker for advanced disease.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Cycle Regulation

Background:

  • The p16 protein is crucial for regulating the G(1)-S cell cycle transition by inhibiting cyclin D-cyclin-dependent kinase (CDK)4/CDK6-mediated phosphorylation of retinoblastoma protein (pRb).
  • Dysregulation of the p16-CDK/cyclin D-pRb pathway is implicated in various cancers, but its role in neuroblastoma, particularly concerning clinical outcome, requires further investigation.

Purpose of the Study:

  • To investigate potential derangements in the p16-CDK/cyclin D-pRb pathway in primary neuroblastomas.
  • To correlate findings with clinical stage and patient survival outcomes.
  • To determine if p16 expression is associated with aggressive neuroblastoma characteristics.

Main Methods:

  • Analysis of 40 primary neuroblastoma samples (18 unfavorable, 22 favorable stages).
  • Utilized Polymerase Chain Reaction (PCR), reverse transcription-PCR, Western blot, and immunohistochemistry.
  • Examined p16 gene alterations, mRNA and protein expression, and retinoblastoma protein (pRb) status.

Main Results:

  • No p16 gene alterations were detected in any samples.
  • Higher frequency of p16 mRNA and protein expression observed in unfavorable stage neuroblastomas compared to favorable stages (p=0.006 for mRNA, p=0.013 for protein).
  • pRb was deregulated in 82% of samples; pRb phosphorylation status did not correlate with p16 protein expression.
  • p16 expression significantly correlated with lower overall survival across all stages.
  • Infrequent events included MDM2 overexpression, p14(ARF) loss, and p53 mutation.

Conclusions:

  • Up-regulated p16 expression is a potential unique feature of aggressive neuroblastoma.
  • Elevated p16 protein may not function properly in regulating the cell cycle pathway in these tumors.
  • p16 expression serves as a significant prognostic marker associated with reduced survival in neuroblastoma patients.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...